Showing results (141-150 of 170) with videos related to
Sort By:
Pageof 17
Children (Basel, Switzerland)|June 26, 2025
Construct Validity and Internal Consistency of the Italian Version of the PedsQLTM 4.0 Generic Core Scale and PedsQLTM 3.0 Cerebral Palsy ModuleIlaria Pedrinelli, Sofia Biagi, Domenico Marco Romeo, et al.Journal of Neuro-Oncology|February 13, 2010
A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade gliomaMaura Massimino, Filippo Spreafico, Daria Riva, et al.Neuro-Ophthalmology (Aeolus Press)|March 9, 2023
Neurovisual Manifestations in Children with Mild COVID-19: An Association to RememberGiorgio Costagliola, Michele Pio Vallario, Andrea Santangelo, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|December 8, 2007
Neurodevelopmental evolution of West syndrome: a 2-year prospective studyFrancesco Guzzetta, Giovanni Cioni, Eugenio Mercuri, et al.The Journal of Pediatrics|September 24, 2013
Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectivesLuca Filippi, Giacomo Cavallaro, Paola Bagnoli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastomaLorenza Gandola, Maura Massimino, Graziella Cefalo, et al.Epilepsia|July 3, 2004
Visual function in infants with West syndrome: correlation with EEG patternsTeresa Randò, Adina Bancale, Giovanni Baranello, et al.Brain & Development|September 16, 2009
The syndrome of perisylvian polymicrogyria with congenital arthrogryposisAnnapurna Poduri, Vida Chitsazzadeh, Stefano D'Arrigo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
High response rate to cisplatin/etoposide regimen in childhood low-grade gliomaMaura Massimino, Filippo Spreafico, Graziella Cefalo, et al.Neuro-Oncology|February 11, 2005
Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade gliomaMaura Massimino, Lorenza Gandola, Roberto Luksch, et al.Pageof 17